Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC
CompletedOBSERVATIONAL
Enrollment
74
Participants
Timeline
Start Date
May 13, 2015
Primary Completion Date
July 7, 2017
Study Completion Date
July 7, 2017
Conditions
Metastatic Breast Cancer
Trial Locations (1)
37203
Tennessee Oncology, Nashville
All Listed Sponsors
lead
SCRI Development Innovations, LLC
OTHER
NCT02436772 - Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC | Biotech Hunter | Biotech Hunter